SK77595A3 - Pharmaceutical and veterinary agent containing the sesquiterpenes and method of their preparation - Google Patents

Pharmaceutical and veterinary agent containing the sesquiterpenes and method of their preparation Download PDF

Info

Publication number
SK77595A3
SK77595A3 SK775-95A SK77595A SK77595A3 SK 77595 A3 SK77595 A3 SK 77595A3 SK 77595 A SK77595 A SK 77595A SK 77595 A3 SK77595 A3 SK 77595A3
Authority
SK
Slovakia
Prior art keywords
cir
sesquiterpene
formula
compound
pharmaceutically
Prior art date
Application number
SK775-95A
Other languages
English (en)
Slovak (sk)
Inventor
Didier V Renno
Gerard B O'beirne
Brent R Copp
Original Assignee
Xenova Limited British Body Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Limited British Body Co filed Critical Xenova Limited British Body Co
Publication of SK77595A3 publication Critical patent/SK77595A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SK775-95A 1992-12-22 1993-12-22 Pharmaceutical and veterinary agent containing the sesquiterpenes and method of their preparation SK77595A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929226724A GB9226724D0 (en) 1992-12-22 1992-12-22 Pharmaceutical compounds
PCT/GB1993/002632 WO1994014814A1 (en) 1992-12-22 1993-12-22 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor

Publications (1)

Publication Number Publication Date
SK77595A3 true SK77595A3 (en) 1995-12-06

Family

ID=10727034

Family Applications (1)

Application Number Title Priority Date Filing Date
SK775-95A SK77595A3 (en) 1992-12-22 1993-12-22 Pharmaceutical and veterinary agent containing the sesquiterpenes and method of their preparation

Country Status (23)

Country Link
US (1) US5565486A (zh)
EP (1) EP0675888A1 (zh)
JP (1) JPH08504804A (zh)
KR (1) KR950704324A (zh)
AU (1) AU677272B2 (zh)
BG (1) BG99736A (zh)
BR (1) BR9307712A (zh)
CA (1) CA2151251A1 (zh)
CZ (1) CZ284121B6 (zh)
FI (1) FI953081A0 (zh)
GB (2) GB9226724D0 (zh)
HU (1) HUT71859A (zh)
IL (1) IL108140A (zh)
MX (1) MX9400174A (zh)
NO (1) NO952483L (zh)
NZ (1) NZ258986A (zh)
PL (1) PL309628A1 (zh)
RU (1) RU95113350A (zh)
SG (1) SG67345A1 (zh)
SK (1) SK77595A3 (zh)
TW (1) TW242141B (zh)
WO (1) WO1994014814A1 (zh)
ZA (1) ZA939626B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
CA2797033C (en) 2010-04-22 2021-10-19 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348284A (ja) * 1986-08-18 1988-02-29 Yamanouchi Pharmaceut Co Ltd 新抗生物質yp−02908l−aおよびその製造法
EP0301102B1 (en) * 1987-02-06 1991-11-06 Snow Brand Milk Products Co., Ltd. NOVEL 7$g(b)-HYDROXY-4-PREGNENE-3,20-DIONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼa▲下2▼阻害物質
JPH03108490A (ja) * 1989-06-30 1991-05-08 Shionogi & Co Ltd フォスフォリパーゼa↓2阻害物質
US5130430A (en) * 1990-10-31 1992-07-14 Neurogen Corporation 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder

Also Published As

Publication number Publication date
GB9503413D0 (en) 1995-04-12
CZ164695A3 (en) 1995-11-15
IL108140A (en) 1997-06-10
NZ258986A (en) 1996-11-26
GB2284603B (en) 1996-03-27
MX9400174A (es) 1994-07-29
AU5709694A (en) 1994-07-19
HUT71859A (en) 1996-02-28
TW242141B (zh) 1995-03-01
IL108140A0 (en) 1994-04-12
CZ284121B6 (cs) 1998-08-12
BR9307712A (pt) 1999-08-31
EP0675888A1 (en) 1995-10-11
BG99736A (bg) 1996-04-30
CA2151251A1 (en) 1994-07-07
HU9501840D0 (en) 1995-08-28
NO952483D0 (no) 1995-06-21
JPH08504804A (ja) 1996-05-28
KR950704324A (ko) 1995-11-17
FI953081A (fi) 1995-06-21
US5565486A (en) 1996-10-15
PL309628A1 (en) 1995-10-30
FI953081A0 (fi) 1995-06-21
GB2284603A (en) 1995-06-14
WO1994014814A1 (en) 1994-07-07
NO952483L (no) 1995-08-15
SG67345A1 (en) 1999-09-21
RU95113350A (ru) 1997-06-10
AU677272B2 (en) 1997-04-17
GB9226724D0 (en) 1993-02-17
ZA939626B (en) 1994-08-18

Similar Documents

Publication Publication Date Title
McBrien et al. Rakicidins, new cytotoxic lipopeptides from Micromonospora sp. fermentation, isolation and characterization
CZ390592A3 (en) Process for preparing 4,5-dihydrogendanamycin and hydroquinone thereof and the use of such compounds
PL179581B1 (pl) kompozycja farmaceutyczna oraz substancja farmakologicznie czynna PL PL PL PL PL PL PL PL
JPH0320279A (ja) 新規免疫抑制剤
EP0634414A1 (en) Isolation and structure of spongistatins 5,7,8,and 9 and their use as antitumor agents
US5430053A (en) Isolation and structure of dictyostatin 1
EP0632042A1 (en) Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6
SK77595A3 (en) Pharmaceutical and veterinary agent containing the sesquiterpenes and method of their preparation
US5712306A (en) Physiologically active substances PF1092A, PF1092B and PF1092C, and contraceptives and anticancer drugs containing the same as active ingredients
EP0087021A2 (en) CL 1565 Antibiotic compounds and their production
JPH024785A (ja) ストレプトミセス属からの新規なフラン類およびラクトン類
US5236929A (en) Compound uca1064-b
JP2002500876A (ja) ウスチリピド、その製法およびその使用
ES2298279T3 (es) Citrulimicinas, un procedimiento para su produccion y su uso como productos farmaceuticos.
JPS59161396A (ja) 新規抗生物質スピカマイシン
KR0130473B1 (ko) 새로운 항생물질, 베나노마이신 a와 b 및 덱실오실베나노마이신 b와 이들의 제조 방법과 용도
CA2037783C (en) Rebeccamycin analogs by tryptophan analogs feeding
JPH05271267A (ja) Fr901459物質、その製法及び用途
US7501431B2 (en) Physiologically active substances PF1270A, B and C substances
EP0591534B1 (en) Substances wb2663, production thereof and use
JPH10101676A (ja) 抗腫瘍性物質be−56384及びその製造法
BAROW et al. WIN 66306, A NEW NEUROKININ ANTAGONIST PRODUCED BY AN Aspergillus species: FERMENTATION, ISOLATION AND PHYSICO-CHEMICAL PROPERTIES
JPH0632796A (ja) ベンズアントラセン誘導体、該誘導体を含有する抗腫瘍剤及びその製造方法
JP2000178274A (ja) 抗腫瘍性物質be−54017及びその製造法
JPH1017527A (ja) 抗菌性物質be−39589類及びその製造法